Themis Medicare Ltd.

₹79.22

5 (6.8%)

THEMISMED Share Price

Pharmaceuticals & Biotechnology

As on April 2, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 731 Cr

P/E Ratio24.44

Dividend Yield0.63 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	72.87	Bullish
10-DMA	73.42	Bullish
20-DMA	76.28	Bullish
50-DMA	81.65	Bearish
100-DMA	93.27	Bearish
200-DMA	106.96	Bearish

Historical Performance

1 Year

-46.6%

3 Years

-32.9%

5 Years

165.9%

10 Years

100.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	4,055	3,818	3,543	3,946	2,307
Total Expenditure	3,565	3,303	2,869	2,990	1,812
Other Income	47	48	115	65	36
Operating Profit	537	563	790	1,022	531
Interest	100	94	96	88	127
Depreciation	99	122	105	95	85
Profit Before Tax	397	534	725	953	413
Consolidated Net Profit	298	435	569	729	357
Adjusted EPS	3	5	6	8	4

Compounded Sales Growth

10 Years:15

5 Years:15

3 Years:0.5

TTM:1.2

Compounded Profit Growth

10 Years:36.9

5 Years:3.8

3 Years:-16.4

TTM:-7.3

Stock Price CAGR

10 Years:7.2

5 Years:21.6

3 Years:-13

TTM:-49.1

Return on Equity

10 Years:1.9

5 Years:3.9

3 Years:6.2

last year:3.2

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	92	92	92	92	92
Total Reserves	3,934	3,685	3,302	2,781	2,090
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	293	358	354	308	243
Other Current Liabilities	537	500	403	299	391
Short Term Borrowings	434	474	489	431	569
Total Liabilities	5,979	5,757	5,242	4,418	3,711
Capital Work in Progress	25	26	26	26	25
Long Term Loans & Advances	133	125	128	69	28
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	327	272	352	343	188
Total Current Assets	3,137	3,025	2,748	2,282	1,855
Total Assets	5,979	5,757	5,242	4,418	3,711
Adjusted Book Value	44	41	37	31	24

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 24.44, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -13.0%, indicating poor shareholder returns.
The stock carries a high beta of 1.9, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹537 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹4055 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 509682.8

No. of Shares: 6434 (Approx)

Performance:-49%

P/L: ₹-490317.2

NIFTY Performance: -2.3%

1 day Top Gainers